ATE532506T1 - Neue aromatische verbindungen und ihre verwendung in medizinischen anwendungen - Google Patents
Neue aromatische verbindungen und ihre verwendung in medizinischen anwendungenInfo
- Publication number
- ATE532506T1 ATE532506T1 AT06792185T AT06792185T ATE532506T1 AT E532506 T1 ATE532506 T1 AT E532506T1 AT 06792185 T AT06792185 T AT 06792185T AT 06792185 T AT06792185 T AT 06792185T AT E532506 T1 ATE532506 T1 AT E532506T1
- Authority
- AT
- Austria
- Prior art keywords
- aromatic compounds
- medical applications
- new aromatic
- formulas
- pharmaceutically acceptable
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Cardiology (AREA)
- Rheumatology (AREA)
- Communicable Diseases (AREA)
- Urology & Nephrology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Physical Education & Sports Medicine (AREA)
- Oncology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Dermatology (AREA)
- Biomedical Technology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Furan Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP05020510A EP1764093A1 (de) | 2005-09-20 | 2005-09-20 | Neue aromatische Verbindungen und deren medizinische Verwendung |
PCT/EP2006/009154 WO2007039113A1 (en) | 2005-09-20 | 2006-09-20 | Novel aromatic compounds and their use in medical applications |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE532506T1 true ATE532506T1 (de) | 2011-11-15 |
Family
ID=35717680
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT06792185T ATE532506T1 (de) | 2005-09-20 | 2006-09-20 | Neue aromatische verbindungen und ihre verwendung in medizinischen anwendungen |
Country Status (5)
Country | Link |
---|---|
US (2) | US7923473B2 (de) |
EP (2) | EP1764093A1 (de) |
JP (1) | JP2009508901A (de) |
AT (1) | ATE532506T1 (de) |
WO (1) | WO2007039113A1 (de) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1577289A1 (de) * | 2004-03-18 | 2005-09-21 | Revotar Biopharmaceuticals AG | Nicht-glykosylierte/-glykosidische/-peptidische keine Moleküle als Selektininhibitoren für die Behandlung entzündlicher Erkrankungen. |
EP1764093A1 (de) | 2005-09-20 | 2007-03-21 | Revotar Biopharmaceuticals AG | Neue aromatische Verbindungen und deren medizinische Verwendung |
EP1764094A1 (de) * | 2005-09-20 | 2007-03-21 | Revotar Biopharmaceuticals AG | Neuartige multi-zyklische Verbindungen und deren Verwendung |
EP1764096A1 (de) | 2005-09-20 | 2007-03-21 | Revotar Biopharmaceuticals AG | Neue Phloroglucinolderivate mit Selectin-Ligand-Aktivität |
EP1764095A1 (de) * | 2005-09-20 | 2007-03-21 | Revotar Biopharmaceuticals AG | Neue Nitrocatecholderivate mit Selectin-Ligand-Activität |
MX2009011816A (es) | 2007-05-03 | 2009-11-19 | Pfizer Ltd | Derivados de piridina. |
Family Cites Families (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4363813A (en) * | 1979-07-09 | 1982-12-14 | Kureha Kagaku Kogyo Kabushiki Kaisha | 2-(3,4,5-Trimethoxyphenyl)-4,5-disubstituted thiazoles |
JPS58156932A (ja) | 1982-03-11 | 1983-09-19 | Fuji Photo Film Co Ltd | ハロゲン化銀カラ−写真感光材料 |
US4757084A (en) * | 1984-02-29 | 1988-07-12 | Merck & Co., Inc. | 2,5-diaryl tetrahydrothiophenes and analogs thereof as PAF-antagonists |
GB2238047B (en) | 1989-11-03 | 1993-02-10 | Orion Yhtymae Oy | Stable polymorphic form of (e)-n,n-diethyl-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)acrylamide and the process for its preparation |
EP0465122A1 (de) * | 1990-06-29 | 1992-01-08 | Merck & Co. Inc. | Verfahren zur Herstellung von 2,5-Diaryl-tetrahydrofuranen und deren Analogen, welche als PAF-Antagonisten verwendbar sind |
US5374772A (en) * | 1992-12-08 | 1994-12-20 | Hoffmann-Laroche Inc. | Substituted benzoic acids, inhibitors of phospholipases A2 |
US5444050A (en) | 1994-04-29 | 1995-08-22 | Texas Biotechnology Corporation | Binding of E-selectin or P-selectin to sialyl Lewisx or sialyl-Lewisa |
EP0840606B1 (de) | 1995-06-29 | 2000-06-07 | Texas Biotechnology Corporation | Di- und trivalente kleine moleküle als selektininhibitoren |
NZ311686A (en) | 1995-06-29 | 2000-01-28 | Novartis Ag | Diglycosylated 1,2-diols as mimetics of sialyl-lewis x and sialyl-lewis a |
JPH10306024A (ja) * | 1997-03-07 | 1998-11-17 | Kissei Pharmaceut Co Ltd | 糸球体疾患の予防および治療剤 |
FR2761066B1 (fr) | 1997-03-24 | 2000-11-24 | Sod Conseils Rech Applic | Nouveaux derives du 2-(iminomethyl)amino-phenyle, leur preparation, leur application a titre de medicaments et les compositions pharmaceutiques les contenant |
US6432657B1 (en) * | 1997-07-23 | 2002-08-13 | Tokuyama Corporation | Method for determining coagulation parameters |
WO1999029705A2 (en) * | 1997-12-08 | 1999-06-17 | Glycomed Incorporated | Sialyl lewis x and sialyl lewis a glycomimetics |
WO1999029706A2 (en) | 1997-12-08 | 1999-06-17 | Glycomed Incorporated | DISALICYLATE ANALOG BASED SIALYL LEWISx MIMETICS |
EP1081151A4 (de) | 1998-05-18 | 2002-10-28 | Mercian Corp | Neue physiologisch aktive substanzen |
AU2039800A (en) | 1998-12-04 | 2000-06-26 | Ontogen Corporation | 5-membered heterocycles for the treatment of human diseases involving modulatorsof selectins |
US6248790B1 (en) * | 2000-06-29 | 2001-06-19 | Parker Hughes Institute | Treatment of inflammation with 2,4,6-trihydroxy-alpha-rho-methoxyphenylacetophenone, or its pharmaceutically acceptable derivatives |
US6432957B1 (en) | 2001-06-29 | 2002-08-13 | Kowa Co., Ltd. | Piperazine derivative |
CA2452159A1 (en) * | 2001-07-23 | 2003-02-06 | Galileo Laboratories, Inc. | Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods |
JP2003055369A (ja) | 2001-08-06 | 2003-02-26 | Univ Nihon | 新規なフロログルシノール誘導体、及びこれを用いた組成物、抗アレルギー剤 |
AU2002246135A1 (en) * | 2002-03-14 | 2003-09-22 | Bobel 246, S.L. | Use of derivatives of 2,4-disubstituted phenols as inhibitors of the expression of l-selectins and of the isoform that is inducible from nitric oxide synthase |
DE60224098T2 (de) * | 2002-03-27 | 2008-12-04 | an Indian Reg. body incorporated under Reg. of Societies Act (Act XXI of 1860) Rafi Marg | Herstellung eines neolignans mittels durch ddq vermittelte dimerisierung von dihydroasaron |
CA2486106C (en) | 2002-05-16 | 2013-07-16 | Glycomimetics, Inc. | Compounds and methods for inhibiting selectin-mediated function |
AU2003250899A1 (en) | 2002-08-09 | 2004-03-11 | Astellas Pharma Europe B.V. | Compounds binding to p-selectin |
US20040110802A1 (en) * | 2002-08-23 | 2004-06-10 | Atli Thorarensen | Antibacterial benzoic acid derivatives |
EP1569907B1 (de) * | 2002-12-13 | 2016-03-09 | YM BioSciences Australia Pty Ltd | Nicotinamid-basierte kinasehemmer |
WO2004056774A2 (en) * | 2002-12-19 | 2004-07-08 | Neurogen Corporation | Substituted biphenyl-4-carboxylic acid arylamide analogues as capsaicin receptor modulators |
WO2004112837A1 (ja) | 2003-05-23 | 2004-12-29 | Hisamitsu Pharmaceutical Co., Inc. | 非ステロイド系消炎鎮痛剤含有外用経皮製剤およびインターロイキン-1α生成抑制剤 |
EP1481669A1 (de) | 2003-05-30 | 2004-12-01 | Yamanouchi Pharmaceutical Co. Ltd. | Verwendung von Polyhydroxyphenolen und Polyphenolen zur Modulation der P-Selektin Aktivität |
JP4667384B2 (ja) * | 2003-10-07 | 2011-04-13 | レノビス, インコーポレイテッド | イオンチャネルリガンドとしてのアミド誘導体および薬学的組成物、ならびにこれらを使用する方法 |
EP1577289A1 (de) | 2004-03-18 | 2005-09-21 | Revotar Biopharmaceuticals AG | Nicht-glykosylierte/-glykosidische/-peptidische keine Moleküle als Selektininhibitoren für die Behandlung entzündlicher Erkrankungen. |
EP1764093A1 (de) | 2005-09-20 | 2007-03-21 | Revotar Biopharmaceuticals AG | Neue aromatische Verbindungen und deren medizinische Verwendung |
EP1764094A1 (de) | 2005-09-20 | 2007-03-21 | Revotar Biopharmaceuticals AG | Neuartige multi-zyklische Verbindungen und deren Verwendung |
EP1764095A1 (de) | 2005-09-20 | 2007-03-21 | Revotar Biopharmaceuticals AG | Neue Nitrocatecholderivate mit Selectin-Ligand-Activität |
EP1764096A1 (de) | 2005-09-20 | 2007-03-21 | Revotar Biopharmaceuticals AG | Neue Phloroglucinolderivate mit Selectin-Ligand-Aktivität |
-
2005
- 2005-09-20 EP EP05020510A patent/EP1764093A1/de not_active Withdrawn
-
2006
- 2006-09-20 JP JP2008531608A patent/JP2009508901A/ja active Pending
- 2006-09-20 WO PCT/EP2006/009154 patent/WO2007039113A1/en active Application Filing
- 2006-09-20 EP EP06792185A patent/EP1940372B1/de not_active Not-in-force
- 2006-09-20 US US12/067,389 patent/US7923473B2/en not_active Expired - Fee Related
- 2006-09-20 AT AT06792185T patent/ATE532506T1/de active
-
2011
- 2011-03-01 US US13/037,575 patent/US8394835B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US20110152291A1 (en) | 2011-06-23 |
US8394835B2 (en) | 2013-03-12 |
US7923473B2 (en) | 2011-04-12 |
WO2007039113A1 (en) | 2007-04-12 |
EP1764093A1 (de) | 2007-03-21 |
EP1940372A1 (de) | 2008-07-09 |
EP1940372B1 (de) | 2011-11-09 |
US20080207639A1 (en) | 2008-08-28 |
JP2009508901A (ja) | 2009-03-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2006299184A8 (en) | Novel nitrocatechol derivatives having selectin ligand activity | |
WO2007039112A8 (en) | Novel phloroglucinol derivatives having selectin ligand activity | |
ATE532506T1 (de) | Neue aromatische verbindungen und ihre verwendung in medizinischen anwendungen | |
CY1118196T1 (el) | Νεα κρυσταλλικη μορφη vi της αγομελατινης, μεθοδος παρασκευης αυτης και οι φαρμακευτικες συνθεσεις που την περιεχουν | |
GEP20146033B (en) | N-(hetero)aryl, 2-(hetero)aryl-substituted acetamides usage as wnt signaling modulators | |
NO20081231L (no) | Kondenserte heterocykliske forbindelser anvendbare som kinasemodulatorer | |
GEP20115241B (en) | Indole compound | |
FI20030958A0 (fi) | Uusia yhdisteitä | |
NO20090321L (no) | Anvendelse av substituerte 2-aminotyetraliner for produksjon av et medikament for forhindringen, lettingen og/eller behandlingen av diverse typer smerte | |
WO2007067711A3 (en) | Certain chemical entities, compositions, and methods for modulating trpv1 | |
BR0311494A (pt) | Novos indóis substituìdos | |
MX2008000255A (es) | Activadores de urea glucocinasa. | |
GEP20115359B (en) | Fused cyclic compounds | |
UA95766C2 (ru) | Производные терфенила для лечения болезни альцгеймера | |
MX2008012399A (es) | Modulacion de cinasa de ceramida. | |
MX2009000657A (es) | Composiciones y metodos para el tratamiento de mucositis. | |
MY148538A (en) | Novel 2-azetidinone derivatives as cholesterol absorption inhibitors for the treatment of hyperlipidaemic conditions | |
BRPI0506477A (pt) | compostos farmaceuticamente úteis e inovadores | |
GB0620259D0 (en) | Pharmaceutical compounds | |
CY1115247T1 (el) | Ενωσεις συμπυκνωμενων δακτυλιων και χρηση αυτων | |
DE602006010738D1 (de) | Pyrroloä2,3-cüpyridinderivate | |
MY148953A (en) | Substituted biphenyl carboxylic acids and derivatives thereof | |
BRPI0615614A2 (pt) | compostos orgánicos | |
CY1111857T1 (el) | Κρυσταλλικη βαση trans-1-((1r,3s)-6-xλωpo-3-φαινυλινδαν-1-υλο)-3,3-διμεθυλοπιπεραζινης | |
WO2007039111A3 (en) | Novel multi-cyclic compounds and their use |